A Gene Therapy of Experimental Parkinsonism Monkeys with Intra-Stristums Implantation of AAV-TH with CT Guiding

王维,毛俊,于小平,刘晟,胡维新,曾赵军,蔡维军,吴小兵

DOI: https://doi.org/10.3760/j.issn:1005-1201.2003.11.015

2003-01-01

Abstract:Objective To observe the transfection ability to neuron and the therapy effect of adeno-associated virus vector (AAV) mediated intracerebal expressing of human tyrosine hydroxylase (TH) in the Rhesus monkey of Parkinson disease with CT guiding. Methods Six Rhesus monkeys were induced into hemi-parkinsonism models by infusion of MPTP into right internal carotid artery. Under the guidance of CT and stereotactic apparatus, the recombinant adeno-associated virus vectors-human tyrosine hydroxylase were injected into the right caudate nucleus of 5 PD monkeys. The motor ability of the PD model was evaluated for 6 months after implantation. The content of DA, DOPAC, and HVA in the caudate nucleus was assayed with HPLC, and the expression of the tyrosine hydroxylase gene was detected with immunohistochemistry and RT-PCR. Results The method of stereotactic puncture guided with CT had the features of real-time operating, fine location, and mini-trauma. The motor ability of all five models was all ameliorated after stereotactical injection of AAV-hTH vectors from two weeks up to six months. One PD monkey did not show any twist in response to apomorphine test. The frequency of twirl in the other 4 PD monkeys in response to apomorphine test was decreased by 42%-70% compared with that preoperatively. The contents of DA and DA metabolites in the lesion caudate nucleus were increased. Many TH positive cells in the implantation sites of caudate nucleus were shown by immunohistochemistry, which was different from the contralateral caudate nucleus. TH-mRNA was found in the treated side of caudate nucleus with RT-PCR, but no positive detection in the untreated side of caudate nucleus or in other sites in the brain. The negative results of RT-PCR were also shown in samples of the heart, liver, kidney tissue, or right side caudate nucleus of the uninjected monkey. Conclusion Under the guidance of CT and stereotactic apparatus, the AAV-hTH vector can be injected accurately into the lesioned caudate nucleus of PD Rhesus monkey model. That can effectually make the neuron express the features of TH gene in definite place. This therapeutic method can increase the caudate nucleus DA content and ameliorate the motor ability of PD model. The result suggests the gene therapy with AAV-hTH is a potentially valuable and safety therapeutic method for the primate model of Parkinsonism, and also provides some reference data of experiment for the clinical trial gene therapy in PD.